2017 Annual Meeting | C212 - Clinical EEG III: Pediatric and Neonatal

Date Thursday 04/27/17

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Susan T. Herman, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to appropriately order EEG studies in the diagnostic evaluation of neurologic disorders in neonates and children, avoiding inappropriate use of EEG; identify normal and abnormal EEG patterns in pediatric patients; correctly interpret focal and diffuse EEG abnormalities in patients with epilepsy, focal brain disorders, and diffuse brain disorders; select the best EEG type in the diagnostic evaluation of epilepsy; identify interictal and ictal epileptiform patterns in neonates and children in outpatient, inpatient, and ICU settings; and correctly interpret focal and generalized epileptiform patterns to aid in seizure and epilepsy syndrome classification.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
03:30 PM - 03:35 PM	Luncheon	Introduction Susan T. Herman, MD, FAAN
03:35 PM - 04:20 PM	Speaker	Normal and Abnormal EEG in Neonates and Children Tammy Tsuchida, MD, PhD
04:20 PM - 05:05 PM	Speaker	Interictal and Ictal EEG in Neonates and Children Tobias Loddenkemper, MD, FAAN
05:05 PM - 05:30 PM	Speaker	EEG Unknowns Tobias Loddenkemper, MD, FAAN, Tammy Tsuchida, MD, PhD

Faculty Disclosures
Susan T. Herman, MD, FAAN	The institution of Dr. Herman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioserenity. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for National Association of Epilepsy Centers. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Herman has received research support from Epilepsy Foundation; Epilepsy Learning Healthcare System. The institution of Dr. Herman has received research support from CREMedical. The institution of Dr. Herman has received research support from NIH/NINDS. The institution of Dr. Herman has received research support from Marinus. The institution of Dr. Herman has received research support from Neuroelectrics, Inc. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as a Medical Director, Neurodiagnostics Program with Laboure College. Dr. Herman has a non-compensated relationship as a Professional Advisory Board member with Epilepsy Foundation that is relevant to AAN interests or activities.
Tammy Tsuchida, MD, PhD	The institution of Dr. Tsuchida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon Pharmaceuticals Inc. The institution of Dr. Tsuchida has received research support from Xenon Pharmaceuticals Inc.
Tobias Loddenkemper, MD, FAAN	No disclosure on file

��ɫ��

��ɫ��